Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PTRF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TRABD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NPAS3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIA-RAB4B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NR2F6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC339539 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
PLEKHM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF40 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CRYBB2P1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
KLF5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP131 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CABP7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM63C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100652930 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NFATC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BCL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AMACR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on